Skip to main content
SpringerLink
Log in
Book cover

Arzneiverordnungs- Report 2014 pp 321–338Cite as

Antiallergika

  • Chapter

  • 1541 Accesses

Zusammenfassung

Größte Gruppe der Antiallergika sind die Hyposensibilisierungsmittel zur allergenspezifischen Immuntherapie bei allergisch bedingten Atemwegskrankheiten. Danach folgen H1-Antihistaminika, die vor allem zur Behandlung des Heuschnupfens, der allergischen Bindehautentzündung und der Urtikaria eingesetzt werden.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arzneimittelkommission der deutschen Ärzteschaft (2007): Stellungnahme der AkdÄ zur allergenspezifischen Immuntherapie.

    Google Scholar 

  • Dtsch Ärztebl 104: A 3355–3357

    Google Scholar 

  • Abramson M, Puy R, Weiner J (2003): Allergen immunotherapy for asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software

    Google Scholar 

  • Adkinson NF, Eggleston PA, Eney D, Goldstein EO, Schuberth KC et al (1997) A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 336:324–331

    Article  CAS  PubMed  Google Scholar 

  • Arvidsson MB, Löwhagen O, Rak S (2002) Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol 109:777–783

    Article  CAS  PubMed  Google Scholar 

  • Aust W, Wichmann G, Dietz A (2010) Therapiekontrolle der Insektengifthyposensibilisierung. Laryngorhinootologie 89:725–728

    Article  CAS  PubMed  Google Scholar 

  • Austen KF (2001) Allergies, anaphylaxis, and systemic mastocytosis. In: Braunwald E et al (eds) Harrison's principles of internal medicine. McGraw-Hill Medical Publishing Division, New York, pp 1913–1922

    Google Scholar 

  • Bousquet J, Hejjaoui A, Clauzel AM, Guerin B, Dhivert H, Skassa-Brociek W, Wichel FB (1988) Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 82:971–977

    Article  CAS  PubMed  Google Scholar 

  • Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al (1999) Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 54:249–260

    Article  CAS  PubMed  Google Scholar 

  • Bundesministerin für Gesundheit (2008): Verordnung über die Ausdehnung der Vorschriften über die Zulassung der Arzneimittel auf Therapieallergene, die für einzelne Personen auf Grund einer Rezeptur hergestellt werden, sowie über Verfahrensregelungen der staatlichen Chargenprüfung (Therapieallergene-Verordnung) vom 7. November 2008. Bundesgesetzblatt 2008 Teil I Nr. 51, Bonn 13. November 2008, Seite 2177–2178. Internet: www.bgbl.de/Xaver/start.xav?startbk=Bundesanzeiger_BGBl

    Google Scholar 

  • Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007 Jan 24(1):CD00193–6

    Google Scholar 

  • Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR (2006) Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118:434–440

    Article  CAS  PubMed  Google Scholar 

  • Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR (2008) Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 121:512–518

    Article  CAS  PubMed  Google Scholar 

  • Deutsche GA, klinische I (2009): Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 18: 508–537. Internet: http://dgaki.de/wp-content/uploads/2010/05/Leitlinie_SIT2009.pdf.

  • Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, Andre C, Beaumont O de, Melac M (2007) Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grasspollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 120:1338–1345

    Article  CAS  PubMed  Google Scholar 

  • Durham SR (2008) Sublingual immunotherapy: what have we learnt from the ‚big trials’? Curr Opin Allergy Clin Immunol 8:577–584

    Article  PubMed  Google Scholar 

  • Durham SR, Walker SM, Varga EM, Jacobson MR, O’Brian F, Noble W et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468–475

    Article  CAS  PubMed  Google Scholar 

  • Golden DB (2005) Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 115:439–447

    Article  PubMed  Google Scholar 

  • Guez S, Vatrinet C, Fadel R, Andre C (2000) House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 55:369–375

    Article  CAS  PubMed  Google Scholar 

  • Hoff M, Krail M, Kästner M, Haustein D, Vieths S (2002) Fusarium culmorum causes strong degradation of pollen allergens in extract mixtures. J Allergy Clin Immunol 109:96–101

    Article  PubMed  Google Scholar 

  • Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB (2013) Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 309:1278–1288

    Article  CAS  PubMed  Google Scholar 

  • Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D (2001): Neubewertung des Risikos von Test- und Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991 bis 2000. Bundesgesunheitsbl – Gesundheitsforsch – Gesundheitsschutz 44: 709–718

    Google Scholar 

  • Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T (2013) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 368:924–935

    Article  CAS  PubMed  Google Scholar 

  • Mellerup MT, Hahn GW, Poulsen LK, Malling HJ (2000) Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 30:1423–1429

    Article  CAS  PubMed  Google Scholar 

  • Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L et al (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J Allergy Clin Immunol 109:251–256

    Article  PubMed  Google Scholar 

  • Moffitt JE, Golden DB, Reisman RE, Lee R, Nicklas R, Freeman T, deshazo R, Tracy J, Bernstein IL, Blessing-Moore J, Khan DA, Lang DM, Portnoy JM, Schuller DE, Spector SL, Tilles SA (2004) Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 114:869–886

    Article  PubMed  Google Scholar 

  • Nelson HS (2007) Allergen immunotherapy: where is it now? J Allergy Clin Immunol 119:769–779

    Article  CAS  PubMed  Google Scholar 

  • Olsen OT, Larsen KR, Jacobsan L, Svedsen UG (1997) A 1-year placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults. Allergy 52:853–859

    Article  CAS  PubMed  Google Scholar 

  • O’Neill SM, Forsyth A (1988) Urticaria. Prescribers J 28:14–20

    Google Scholar 

  • Petersen BN, Janniche H, Munch EP, Wihl JA, Bowadt H, Ipsen H, Lowenstein H (1988) Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 43:353–362

    Article  CAS  PubMed  Google Scholar 

  • Pfaar O, Jung K, Wolf H, Decot E, Kleine-Tebbe J, Klimek L, Wüstenberg E (2012) Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio. Allergy 67:630–637

    Article  CAS  PubMed  Google Scholar 

  • Pichler CE, Helbling A, Pichler WJ (2001) Three years of specific immunotherapy with housedust- mite extracts in patients with rhinitis and asthma: significant improvement of allergen- specific parameters and of nonspecific bronchial hyperreactivity. Allergy 56: 301–306 Pichler CE, Marquardsen A, Sparholt S, Lowenstein H, Bircher A, Bischof M, Pichler WJ (1997): Specific immunotherapy with Dermatophagoides ptheronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy 52:274–283

    Article  Google Scholar 

  • Radulovic S, Wilson D, Calderon M, Durham S (2011) Systematic reviews of sublingual immunotherapy (SLIT). Allergy 66:740–752

    Article  CAS  PubMed  Google Scholar 

  • Rietschel E, Hutegger I, Lange L, Urbanek R (2013) Anaphylaxie – Diagnostisches und therapeutisches Vorgehen. Med Klin Intensivmed Notfmed 108:239–249

    Article  CAS  PubMed  Google Scholar 

  • Ring J, Fuchs T, Schultze-Werninghaus G (Hrsg) (2004) DGAI, ÄDA, DAAU: Weißbuch Allergie in Deutschland, 2. Aufl. Urban und Vogel München

    Google Scholar 

  • Routledge PA, Lindquist M, Edwards IR (1999) Spontaneous reporting of suspected adverse reactions to antihistamines: a national and international perspective. Clin Exp Allergy 29(Suppl 3):240–246

    Article  PubMed  Google Scholar 

  • Ruëff F, Wenderoth A, Przybilla B (2001) Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 108:1027–1032

    Article  PubMed  Google Scholar 

  • Sennekamp J, Fuchs Th, Hornung B, Kersten W, Klimek L, Leupold W, Merk H, Rebien W, Schultze-Werninghaus G (2002) Empfehlungen zur praktischen Durchführung der spezifischen Immuntherapie mit Allergenen. Allergo J 11:332–338

    Google Scholar 

  • Simons FE, Simons KJ (2011) Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 128:1139–1150

    Article  CAS  PubMed  Google Scholar 

  • Valsecchi R, di Landro A, Pansera B, Cainelli T (1994) Contact dermatitis from a gel containing dimethindene maleate. Contact Dermat 30:248–249

    Google Scholar 

  • WHO Position Paper (1998) Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53(Suppl 1):1–42

    Google Scholar 

  • Wilson DR, Torres-Lima M, Durham SR (2010) Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010 Dec 8(12):CD00289–3

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wissenschaftliches Institut, AOK, Rosenthaler Straße 31, 10178, Berlin

    Dr. rer. nat. Anette Zawinell

  2. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Prof. Dr. med. Ulrich Schwabe

Authors
  1. Dr. rer. nat. Anette Zawinell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Ulrich Schwabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zawinell, A., Schwabe, U. (2014). Antiallergika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs- Report 2014. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43487-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43487-1_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43486-4

  • Online ISBN: 978-3-662-43487-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation